Bio-Works Technologies AB (BIOWKS) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.085x

Based on the latest financial reports, Bio-Works Technologies AB (BIOWKS) has a cash flow conversion efficiency ratio of -0.085x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.17 Million ≈ $-449.08K USD) by net assets (Skr49.21 Million ≈ $5.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Bio-Works Technologies AB to measure how many days the company can operate on defensive assets alone.

Bio-Works Technologies AB - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Bio-Works Technologies AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bio-Works Technologies AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-Works Technologies AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kentucky First Federal Bancorp NASDAQ:KFFB	0.018x
ITV PLC LSE:ITV	0.025x
Team Young Advanced Technology Co Ltd TWO:5345	-0.242x
LAVA THERAP. B.V. EO-12 F:4PKB	N/A
Alpine Summit Energy Partners Inc NASDAQ:ALPS	0.022x
DP Aircraft I Limited LSE:DPA	0.082x
Coda Minerals Ltd AU:COD	-0.136x
CORESTATE Capital Holding S.A F:CCAP	N/A

Annual Cash Flow Conversion Efficiency for Bio-Works Technologies AB (2015–2025)

The table below shows the annual cash flow conversion efficiency of Bio-Works Technologies AB from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Bio-Works Technologies AB.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr49.21 Million ≈ $5.30 Million	Skr-18.81 Million ≈ $-2.02 Million	-0.382x	+60.52%
2024-12-31	Skr44.58 Million ≈ $4.80 Million	Skr-43.17 Million ≈ $-4.65 Million	-0.968x	+27.73%
2023-12-31	Skr44.03 Million ≈ $4.74 Million	Skr-58.99 Million ≈ $-6.35 Million	-1.340x	-127.40%
2022-12-31	Skr67.69 Million ≈ $7.28 Million	Skr-39.88 Million ≈ $-4.29 Million	-0.589x	-378.17%
2021-12-31	Skr108.51 Million ≈ $11.68 Million	Skr-13.37 Million ≈ $-1.44 Million	-0.123x	+89.36%
2020-12-31	Skr37.46 Million ≈ $4.03 Million	Skr-43.36 Million ≈ $-4.67 Million	-1.158x	-137.44%
2019-12-31	Skr82.13 Million ≈ $8.84 Million	Skr-40.04 Million ≈ $-4.31 Million	-0.488x	+13.37%
2018-12-31	Skr61.64 Million ≈ $6.63 Million	Skr-34.69 Million ≈ $-3.73 Million	-0.563x	-163.23%
2017-12-31	Skr99.32 Million ≈ $10.69 Million	Skr-21.23 Million ≈ $-2.28 Million	-0.214x	+65.04%
2016-12-31	Skr23.64 Million ≈ $2.54 Million	Skr-14.46 Million ≈ $-1.56 Million	-0.612x	-4.42%
2015-12-31	Skr22.41 Million ≈ $2.41 Million	Skr-13.12 Million ≈ $-1.41 Million	-0.586x	--

About Bio-Works Technologies AB

ST:BIOWKS Sweden Medical Instruments & Supplies

Market Cap

$38.42 Million

Skr357.04 Million SEK

Market Cap Rank

#22911 Global

#433 in Sweden

Share Price

Skr3.57

Change (1 day)

+5.00%

52-Week Range

Skr1.48 - Skr4.68

All Time High

Skr28.60